keyword
MENU ▼
Read by QxMD icon Read
search

HAART

keyword
https://www.readbyqxmd.com/read/28646196/nucleoside-reverse-transcriptase-inhibitors-nrtis-induce-proinflammatory-cytokines-in-the-cns-via-wnt5a-signaling
#1
Ting Wu, Juan Zhang, Mingxing Geng, Shao-Jun Tang, Wenping Zhang, Jianhong Shu
HAART is very effective in suppressing HIV-1 replication in patients. However, patients staying on long-term HAART still develop various HIV-associated neurological disorders, even when the viral load is low. The underlying pathogenic mechanisms are largely unknown. Emerging evidence implicated that persistent neuroinflammation plays an important role in NeuroAIDS. Although residual virus or viral proteins are commonly thought as the causal factors, we are interested in the alternative possibility that HAART critically contributes to the neuroinflammation in the central nervous system (CNS)...
June 23, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28633734/cutaneous-hiv-associated-kaposi-sarcoma-a-potential-setting-for-management-by-clinical-observation
#2
Surget V Beatrous, Stratton B Grisoli, Ryan R Riahi, Philip R Cohen
Kaposi sarcoma (KS) is a malignancy of viral etiology whose course ranges from cutaneous limited lesions to fulminant disease with multi-organ involvement. Four clinical variants of the disease exist: classic, endemic, iatrogenic, and epidemic. Iatrogenic and epidemic variants of Kaposi sarcoma develop in the setting of immune suppression. Transplant recipients who develop iatrogenic KS typically demonstrate improvement of lesions following de-escalation of immunosuppressive therapy. Similarly, HIV-infected patients who begin highly active antiretroviral therapy (HAART) experience immune reconstitution, which can induce KS regression...
June 15, 2017: Dermatology Online Journal
https://www.readbyqxmd.com/read/28633458/causes-of-death-and-mortality-trends-of-all-individuals-reported-with-hiv-aids-in-israel-1985-2010
#3
Zohar Mor, Rivka Sheffer, Daniel Chemtob
Background: Highly active antiretroviral therapy (HAART) has changed life-expectancy and mortality trends among people living with HIV/AIDS (PLWHA) since 1996. This retrospective cohort study aimed to assess the mortality epidemiology of PLWHA in Israel and analyze the causes of death. Methods: This cohort study included all adult Israeli-citizens PLWHA between 1985 and 2010 and crossed matched with the Civil Registry to identify those who died. Death certificates were classified into AIDS or non-AIDS deaths related-causes...
June 17, 2017: Journal of Public Health
https://www.readbyqxmd.com/read/28627655/elevated-expression-of-mir-155-is-associated-with-the-differentiation-of-cd8-t-cells-in-patients-with-hiv-1
#4
Changzhong Jin, Linfang Cheng, Xiangyun Lu, Tiansheng Xie, Haibo Wu, Nanping Wu
The differentiation and response ofCD8+ T cells is vital in host defense against human immunodeficiency virus type 1 (HIV-1). MicroRNA (miR)‑155 is an important regulator of T cell differentiation. However, the profile of miR-155 in HIV‑1 infected individuals and its association with CD8+ T cell differentiation remain to be fully elucidated. The present cross‑sectional study was performed involving 63 HIV‑1‑infected patients undergoing highly active antiretroviral therapy (HAART), 31 HAART‑naïve patients and 35 healthy controls...
June 12, 2017: Molecular Medicine Reports
https://www.readbyqxmd.com/read/28608664/trend-of-cd4-cell-counts-at-diagnosis-and-initiation-of-highly-active-antiretroviral-therapy-haart-korea-hiv-aids-cohort-study-1992-2015
#5
Min Jung Kim, Hyun Ha Chang, Sang Il Kim, Youn Jeong Kim, Dae Won Park, Chun Kang, Mee Kyung Kee, Ju Yeon Choi, Soo Min Kim, Bo Youl Choi, Woo Joo Kim, June Myung Kim, Jun Yong Choi, Young Hwa Choi, Jin Soo Lee, Shin Woo Kim
BACKGROUND: CD4+ cell counts reflect immunologic status of human immunodeficiency virus (HIV) patients. Recommended CD4+ cell counts for the initiation of highly active antiretroviral therapy (HAART) has increased over the past several years in various HIV treatment guidelines. We investigated the trend of CD4+ cell counts at diagnosis and treatment start using data from the Korea HIV/acquired immune deficiency syndrome (AIDS) Cohort Study. MATERIALS AND METHODS: The Korea HIV/AIDS Cohort Study started in 2006 and enrolled HIV patients from 21 tertiary and secondary hospitals in South Korea...
June 1, 2017: Infection & Chemotherapy
https://www.readbyqxmd.com/read/28604545/gluteal-augmentation-with-intramuscular-implants-in-patients-with-human-immunodeficiency-virus-with-lipoatrophy-related-to-the-use-of-antiretroviral-therapy
#6
Guilherme Augusto Andrade, Pedro Soler Coltro, Mário Eduardo Barros, Bruno Francisco Müller Neto, Renan Victor Lima, Jayme Adriano Farina
INTRODUCTION: Lipodystrophy syndrome associated with highly active antiretroviral therapy (HAART) may lead to low self-esteem and poor compliance with the drug treatment on patients infected with human immunodeficiency virus (HIV), which is a matter of concern for the health system. The aim of this study was to evaluate patients with HIV submitted to gluteal augmentation with intramuscular silicone implants to correct gluteal lipoatrophy related to the use of HAART. METHODS: This is a retrospective evaluation of 10 patients submitted to gluteal augmentation with intramuscular silicone implant for correction of gluteal lipoatrophy related to the use of HAART, operated between 2012 and 2015...
June 9, 2017: Annals of Plastic Surgery
https://www.readbyqxmd.com/read/28604324/cytomegalovirus-retinitis-in-cape-town-south-africa-clinical-management-and-outcomes
#7
Steven R J Lapere, James C Rice
BACKGROUND: Cytomegalovirus (CMV) retinitis is a vision-threatening opportunistic infection that occurs mainly in immunocompromised individuals. Limited data on treatment protocols and management outcomes are available in South Africa (SA). OBJECTIVES: To review the clinical presentation, management and outcomes of patients who were diagnosed and treated for CMV retinitis at Groote Schuur Hospital, Cape Town, SA, over a 10-year period, and to compare treatment protocols of 13 public hospitals in SA that treat patients for CMV retinitis...
May 24, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
https://www.readbyqxmd.com/read/28598048/hepatotoxicity-in-hiv-patients-an-observational-study-in-patients-from-tertiary-care-centre-of-western-india
#8
Smrati Bajpai, Kavita Joshi
OBJECTIVE: HIV AIDS has currently become a chronic manageable condition with HAART, but with its chronicity and lifelong therapy currently the adverse drug reactions to these drugs are the main concern for any treating physician. Hepatotoxicity is one of the prime concerns of any physician managing HIV patients. We observe a number of patients reporting hepatotoxicity in our cohort and this had great impact on the efficacy and intake of the HAART drugs, this led us to explore this area and to find out the prevalence and etiologies in our cohort...
May 2017: Journal of the Association of Physicians of India
https://www.readbyqxmd.com/read/28595630/prevalence-and-risk-factors-of-poor-immune-recovery-among-adult-hiv-patients-attending-care-and-treatment-centre-in-northwestern-tanzania-following-the-use-of-highly-active-antiretroviral-therapy-a-retrospective-study
#9
Daniel W Gunda, Semvua B Kilonzo, Erasmus Kamugisha, Engelbert Z Rauya, Bonaventura C Mpondo
BACKGROUND: Highly Active Antiretroviral therapy (HAART) reverses the effect of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) by durably suppressing viral replication. This allows CD4 gain to levels that are adequate enough to restore the body's capability to fight against opportunistic infections (OIs). Patients with poor immune recovery have been shown to have higher risk of developing both AIDS and non AIDS related clinical events. This study aimed at assessing the proportions and risk factors of poor immune recovery in adult HIV-infected patients on 48 months of HAART attending care and treatment center (CTC) in northwestern Tanzania...
June 8, 2017: BMC Research Notes
https://www.readbyqxmd.com/read/28591373/-vulnerability-to-hiv-infection-in-serodiscordant-couples-in-rio-de-janeiro-brazil
#10
Nilo Martinez Fernandes, Élida Azevedo Hennington, Jefferson de Souza Bernardes, Beatriz G Grinsztejn
A new era in HIV/AIDS treatment began in 1996 with the advent of highly active antiretroviral therapy (HAART). The advent of these new medicines expanded the treatment resources and improved life expectancy and quality of life for persons living with HIV and AIDS, favoring the maintenance and initiation of relationships between partners with discordant HIV serological status. The main objective of this study with serodiscordant couples was to understand the three dimensions of vulnerability - programmatic, social, and individual - in these couples...
June 1, 2017: Cadernos de Saúde Pública
https://www.readbyqxmd.com/read/28584718/the-increasing-prevalence-of-hiv-helicobacter-pylori-co-infection-over-time-along-with-the-evolution-of-antiretroviral-therapy-art
#11
Aleksandra Radovanović Spurnić, Branko Brmbolić, Zorica Stojšić, Tatijana Pekmezović, Zoran Bukumirić, Miloš Korać, Dubravka Salemović, Ivana Pešić-Pavlović, Goran Stevanović, Ivana Milošević, Djordje Jevtović
Helicobacter pylori (H. pylori) is one of the most common human bacterial infections with prevalence rates between 10-80% depending upon geographical location, age and socioeconomic status. H. pylori is commonly found in patients complaining of dyspepsia and is a common cause of gastritis. During the course of their infection, people living with HIV (PLHIV) often have a variety of gastrointestinal symptoms including dyspepsia and while previous studies have reported HIV and H. pylori co-infection, there has been little data clarifying the factors influencing this...
2017: PeerJ
https://www.readbyqxmd.com/read/28583495/prevalence-of-hearing-loss-among-haart-treated-children-in-the-horn-of-africa
#12
Alden F Smith, David C Ianacone, Robbert J H Ensink, Abebe Melaku, Margaretha L Casselbrant, Glenn Isaacson
OBJECTIVES: The prevalence of hearing loss (HL) in children infected with HIV/AIDS is not well studied. Even fewer studies focus on stable HIV-infected children treated with high-effective antiretroviral therapy (HAART). We aim to compare the prevalence of ear disease and HL in HAART-treated, HIV + children in Addis Ababa, Ethiopia with a well, similarly-aged elementary school population with unknown HIV status (HIVU). METHODS: Children underwent standard head and neck examination and cerumen removal by board certified otolaryngologists...
July 2017: International Journal of Pediatric Otorhinolaryngology
https://www.readbyqxmd.com/read/28574002/management-of-a-rare-presentation-of-vogt-koyanagi-harada-disease-in-human-immunodeficiency-virus-acquired-immunodeficiency-disease-syndrome-patient
#13
D Priya, S Sudharshan, Jyotirmay Biswas
Vogt-Koyanagi-Harada (VKH), a multisystem autoimmune bilateral panuveitis with systemic manifestations, is uncommon in immunocompromised patients such as human immunodeficiency virus (HIV)/acquired immunodeficiency disease syndrome (AIDS). We report a rare presentation of VKH in a 45-year-old HIV-positive female on highly active antiretroviral therapy (HAART) who presented with a history of recurrent panuveitis. A diagnosis of probable VKH was made based on ocular and systemic signs and symptoms. She was treated with topical and systemic steroids with close monitoring of CD4 counts and viral loads...
May 2017: Indian Journal of Ophthalmology
https://www.readbyqxmd.com/read/28570506/strategies-for-preventing-hiv-infection-among-hiv-uninfected-women-attempting-conception-with-hiv-infected-men-united-states
#14
REVIEW
Jennifer F Kawwass, Dawn K Smith, Dmitry M Kissin, Lisa B Haddad, Sheree L Boulet, Saswati Sunderam, Denise J Jamieson
By the end of 2014, a total of 955,081 persons in the United States (299.5 per 100,000 population) had received a diagnosis of human immunodeficiency virus type 1 (HIV-1) infection (1). The annual estimated number of HIV infections and incidence rate in the United States decreased from 2010 to 2014, and the survival rate has increased over time (1). Effective highly active antiretroviral therapy (HAART) is helping persons with HIV to live longer, healthier lives. Many of these persons, including an unknown percentage in discordant relationships (i...
June 2, 2017: MMWR. Morbidity and Mortality Weekly Report
https://www.readbyqxmd.com/read/28560146/endobronchial-primary-large-b-cell-non-hodgkin-lymphoma-in-hiv-infected-patient-in-the-highly-active-antiretroviral-therapy-era-description-of-a-case-report
#15
U Caterino, O Tambaro, G Palmiero, F Borrelli, M Cotugno, G Bonadies
We report an unusual case of endobronchial primary large B-cell Non Hodgkin Lymphoma in a HIV-infected patient in the course of effective Highly Active Antiretroviral Therapy (HAART). Diagnosis of large B-cell NHL was obtained by fibreoptic bronchoscopy (FOB) biopsies. Three cycles of R-CHOP chemotherapy (rituximab, vincristine, cyclophosphamide, hydroxydaunorubicin, prednisone) was performed and clinical and radiological remission was obtained after 3 cycles of therapy.
2017: Respiratory Medicine Case Reports
https://www.readbyqxmd.com/read/28559937/the-role-of-nuclear-medicine-in-the-staging-and-management-of-human-immune-deficiency-virus-infection-and-associated-diseases
#16
REVIEW
Alfred O Ankrah, Andor W J M Glaudemans, Hans C Klein, Rudi A J O Dierckx, Mike Sathekge
Human immune deficiency virus (HIV) is a leading cause of death. It attacks the immune system, thereby rendering the infected host susceptible to many HIV-associated infections, malignancies and neurocognitive disorders. The altered immune system affects the way the human host responds to disease, resulting in atypical presentation of these disorders. This presents a diagnostic challenge and the clinician must use all diagnostic avenues available to diagnose and manage these conditions. The advent of highly active antiretroviral therapy (HAART) has markedly reduced the mortality associated with HIV infection but has also brought in its wake problems associated with adverse effects or drug interaction and may even modulate some of the HIV-associated disorders to the detriment of the infected human host...
June 2017: Nuclear Medicine and Molecular Imaging
https://www.readbyqxmd.com/read/28546937/ocular-manifestation-and-their-associated-factors-among-hiv-aids-patients-receiving-highly-active-antiretroviral-therapy-in-southern-ethiopia
#17
Anteneh Amsalu, Kindie Desta, Demiss Nigussie, Demoze Delelegne
AIM: To assess the pattern of ocular manifestation and associated factors among human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients on highly active antiretroviral therapy (HAART) at Hawassa University Referral Hospital, Southern Ethiopia. METHODS: A cross sectional study was conducted from January 2014 to April 2015. After obtaining informed written consent, 240 adult HIV/AIDS patients on HAART were randomly selected regardless of their ophthalmic symptoms, WHO status or CD4 count...
2017: International Journal of Ophthalmology
https://www.readbyqxmd.com/read/28537651/the-burden-of-hiv-associated-neurocognitive-disorder-hand-in-post-haart-era-a-multidisciplinary-review-of-the-literature
#18
G Caruana, G Vidili, P A Serra, P Bagella, A Spanu, V Fiore, D F Calvisi, R Manetti, G Rocchitta, S Nuvoli, S Babudieri, M M Simile, G Madeddu
OBJECTIVE: The purpose of the present multidisciplinary review is to give an updated insight into the most recent findings regarding the pathophysiology, diagnosis and therapeutics of HIV-associated neurocognitive disorder (HAND). MATERIALS AND METHODS: We performed a comprehensive search, through electronic databases (Pubmed - MEDLINE) and search engines (Google Scholar), of peer-reviewed publications (articles and reviews) and conferences proceedings on HAND pathophysiology, diagnosis, and therapy, from 1999 to 2016...
May 2017: European Review for Medical and Pharmacological Sciences
https://www.readbyqxmd.com/read/28537061/dolutegravir-lamivudine-as-initial-therapy-in-hiv-1-infected-arv-naive-patients-48-week-results-of-the-paddle-pilot-antiretroviral-design-with-dolutegravir-lamivudine-study
#19
Pedro Cahn, María José Rolón, María Inés Figueroa, Ana Gun, Patricia Patterson, Omar Sued
INTRODUCTION: A proof-of-concept study was designed to evaluate the antiviral efficacy, safety and tolerability of a two-drug regimen with dolutegravir 50 mg once daily (QD) plus lamivudine 300 mg once daily as initial highly active antiretroviral therapy (HAART) among antiretroviral (ARV)-naive patients. METHODS: PADDLE is a pilot study including 20 treatment-naive adults. To be selected, participants had no IAS-USA-defined resistance, HIV-1 RNA ≤100,000 copies/mL at screening and negative HBsAg...
May 9, 2017: Journal of the International AIDS Society
https://www.readbyqxmd.com/read/28534886/a-new-hiv-paradigm-dual-antiretroviral-regimens-as-maintenance-therapy
#20
Vicente Soriano, José M Peña
Since the advent of triple combination antiretroviral therapy in 1996, the prognosis of HIV-infected persons has improved drastically. The clinical benefits of HAART derive from producing sustained viral load suppression and CD4 gains. The major drawbacks of the first HAART regimens were common adverse events and high pill burden, which resulted in difficult drug adherence and led to frequent discontinuations and selection of drug resistance.
May 23, 2017: AIDS Reviews
keyword
keyword
8056
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"